Literature DB >> 27166305

Stability of serum high-density lipoprotein-microRNAs for preanalytical conditions.

Hiroaki Ishikawa1, Hiroya Yamada2, Nao Taromaru3, Kanako Kondo3, Ayuri Nagura3, Mirai Yamazaki3, Yoshitaka Ando4, Eiji Munetsuna5, Koji Suzuki6, Koji Ohashi3, Ryoji Teradaira3.   

Abstract

Background Recently, several studies have shown that microRNAs are present in high-density lipoprotein, and high-density lipoprotein-microRNA may be a promising disease biomarker. We investigated the stability of high-density lipoprotein-microRNAs in different storage conditions as this is an important issue for its application to the field of clinical research. Methods microRNAs were extracted from the high-density lipoprotein fraction that was purified from the serum. miR-135 a and miR-223, which are known to be present in high-density lipoprotein, were quantified by quantitative real-time PCR. The influence of preanalytical parameters on the analysis of high-density lipoprotein-miRNAs was examined by the effect of RNase, storage conditions, and freezing and thawing. Results The concentrations of microRNA in high-density lipoprotein were not altered by RNase A treatment (0-100 U/mL). No significant change in these microRNAs was observed after storing serum at room temperature or 4℃ for 0-24 h, and there was a similar result in the cryopreservation for up to two weeks. Also, high-density lipoprotein-microRNAs were stable for, at least, up to five freeze-thaw cycles. Conclusions These results demonstrated that high-density lipoprotein-microRNAs are relatively resistant to various storage conditions. This study provides new and important information on the stability of high-density lipoprotein-microRNAs.

Entities:  

Keywords:  Circulating miRNA; high-density lipoprotein; high-density lipoprotein-miRNA; high-density lipoprotein-miRNA stability

Mesh:

Substances:

Year:  2016        PMID: 27166305     DOI: 10.1177/0004563216647086

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  6 in total

1.  Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer.

Authors:  Jonas Dohmen; Alexander Semaan; Makbule Kobilay; Martin Zaleski; Vittorio Branchi; Anja Schlierf; Karina Hettwer; Steffen Uhlig; Gunther Hartmann; Jörg C Kalff; Hanno Matthaei; Philipp Lingohr; Stefan Holdenrieder
Journal:  Diagnostics (Basel)       Date:  2022-06-08

2.  Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA.

Authors:  Martin Zaleski; Makbule Kobilay; Lars Schroeder; Manuel Debald; Alexander Semaan; Karina Hettwer; Steffen Uhlig; Walther Kuhn; Gunther Hartmann; Stefan Holdenrieder
Journal:  Oncotarget       Date:  2018-04-27

3.  Plasma microRNA detection standardization test.

Authors:  Xiaomin Feng; Yuwei Liu; Nan Wan
Journal:  J Clin Lab Anal       Date:  2019-10-15       Impact factor: 2.352

Review 4.  Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer.

Authors:  Tana Machackova; Vladimir Prochazka; Zdenek Kala; Ondrej Slaby
Journal:  Cancers (Basel)       Date:  2019-10-12       Impact factor: 6.639

5.  Aberrant expression of HDL-bound microRNA induced by a high-fat diet in a pig model: implications in the pathogenesis of dyslipidaemia.

Authors:  Guoyuan Sui; Lianqun Jia; Nan Song; Dongyu Min; Si Chen; Yao Wu; Guanlin Yang
Journal:  BMC Cardiovasc Disord       Date:  2021-06-06       Impact factor: 2.298

Review 6.  Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis.

Authors:  Diana Gabriela Iacob; Adelina Rosca; Simona Maria Ruta
Journal:  World J Gastroenterol       Date:  2020-03-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.